Rigel Pharmaceuticals Inc share price logo

Rigel Pharmaceuticals Inc Share Price

NASDAQ: RIGL

Small Cap

$36.97

-0.99

(-2.61%)

Live

as on

Rigel Pharmaceuticals Inc Stock Performance

as on September 15, 2025 at 9:42 pm IST

  • Day's Low

    Day's High

    $36.7
    $38.64
    downward going graph

    0.73%

    Downside

    4.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.37
    $43.72
    downward going graph

    63.84%

    Downside

    18.25%

    Upside

    downward going graph

Rigel Pharmaceuticals Inc share price movements today

Previous Close
$37.96
Open
$38.16
Volume
451.3K
Day's Low - High
$36.7 - $38.64
52 Week Low - High
$13.37 - $43.72

Rigel Pharmaceuticals Inc Historical Returns

1 Month Return
-3.92 %
3 Month Return
+ 84.99 %
1 Year Return
+ 177.08 %
3 Year Return
+ 187.58 %
5 Year Return
+ 53.68 %

Rigel Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Rigel Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$680.9M

EPS (TTM)

4.912

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

17.87%

PE Ratio (TTM)

6.99

Industry PE ratio

-3.8535542168674697

P/B Ratio

6.9908

PEG Ratio

-0.1

EBITDA

107.0M

Revenue (TTM)

267.9M

Profit Margin

36.51%

Return On Equity TTM

37.61%

Rigel Pharmaceuticals Inc Stock Valuation

Track how Rigel Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Rigel Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (3.50x)

June 30, 2025

Industry (-3.85x)

September 15, 2025

Today (6.99x)

September 15, 2025

Highest (19.79x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 6.99x

Rigel Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rigel Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$680.9M53.68%6.9936.51%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Rigel Pharmaceuticals Inc Stock including INR - Dollar returns

The Rigel Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rigel Pharmaceuticals Inc investment value today

Current value as on today

₹2,74,839

Returns

₹1,74,839

(+174.84%)

Returns from Rigel Pharmaceuticals Inc Stock

₹1,69,854 (+169.85%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Rigel Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

58.33%

Buy

41.67%

Hold

0.00%

Sell

Based on 12 analysts, 58.33% of analysts recommend a 'BUY' rating for Rigel Pharmaceuticals Inc. Average target price of $38.33

Rigel Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Rigel Pharmaceuticals Inc.

What analysts predicted

3.55%UPSIDE

Target Price

$38.33

Current Price

$36.97

Analyzed by

12 Analysts

Target

$38.33

Rigel Pharmaceuticals Inc target price $38.33, a slight upside of 3.55% compared to current price of $36.97. According to 12 analysts rating.

Rigel Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Rigel Pharmaceuticals Inc Stock has increased by 321% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:321% versus previous 30 day period

Rigel Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
26
26
28
35
29
36
55
57
53
101
Gross Profit
25
25
26
32
27
34
47
51
48
97
Operating Income
-12
-5
-4
1
-6
0
14
16
12
61
EBITDA
-11
-4
-3
2
-5
1
15
17
13
62
Interest Expense
1
1
1
1
1
2
2
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-6
-5
0
-8
-1
12
15
11
59
Income Tax Expense
0
0
0
0
0
-
-
0
0
0
Net Income
-13
-6
-5
0
-8
-1
12
14
11
59
Net Profit Margin
-51.92%
-24.55%
-20.23%
2.06%
-27.92%
-2.80%
22.46%
24.90%
21.46%
58.63%

Rigel Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
28
20
4
44
59
108
149
120
116
179
Gross Profit
-33
-43
-41
44
58
107
148
118
109
160
Operating Income
-51
-69
-79
-72
-69
-28
-8
-55
-20
24
EBITDA
-50
-63
-77
-72
-65
-27
-11
-53
-16
28
Interest Expense
-
-
-
-
0
1
4
3
6
7
Depreciation
-
-
0
0
0
0
1
0
1
2
Income Before Tax
-51
-69
-77
-70
-66
-29
-17
-58
-25
18
Income Tax Expense
-1
4
-2
2
0
0
0
3
2
0
Net Income
-51
-69
-77
-70
-66
-29
-17
-58
-25
17
Net Profit Margin
-178.11%
-339.58%
-1739.34%
-158.35%
-112.24%
-27.38%
-12.00%
-48.71%
-21.47%
9.75%

Rigel Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-6
-5
0
-8
-1
12
14
11
59
Operating Cash Flow
5
-1
-6
-5
0
21
14
0
30
Investing Cash Flow
2
-1
-6
0
10
3
-10
-10
-23
Financing Cash Flow
0
0
0
-2
0
-9
1
0
0
Change in Cash
8
-3
-12
-7
10
15
5
-10
7

Rigel Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-69
-77
-70
-66
-29
-17
-58
-25
17
Operating Cash Flow
-75
-77
-58
-41
-52
5
-73
-5
31
Investing Cash Flow
24
-19
24
-23
47
-80
72
-4
4
Financing Cash Flow
25
117
71
11
12
62
6
18
-11
Change in Cash
-25
20
38
-53
7
-11
5
8
23

Global Institutional Holdings in Rigel Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
9.66%
Morgan Stanley - Brokerage Accounts
8.57%
Armistice Capital, LLC
8.45%
Soleus Capital Management, L.P.
6.3%
Vanguard Group Inc
5.73%

Insights on Rigel Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 11.44M → 59.61M (in $), with an average increase of 80.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RIGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 53.33M → 101.68M (in $), with an average increase of 47.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RIGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RIGL stock has moved down by -7.1%

About Rigel Pharmaceuticals Inc

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
OrganisationRigel Pharmaceuticals Inc
Headquarters611 Gateway Boulevard, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEOMr. Raul R. Rodriguez
E-voting on sharesClick here to vote

Key Management of Rigel Pharmaceuticals Inc

Name

Title

Mr. David A. Santos

Executive VP & Chief Commercial Officer

Dr. Lisa Rojkjaer M.D.

Executive VP & Chief Medical Officer

Ms. Julie Patel

Senior VP of Human Resources

Mr. Joseph Lasaga

Executive VP & Chief Business Officer

Mr. Tarek Sallam

Vice President of Marketing

Mr. Raul R. Rodriguez

President, CEO & Director

Mr. Dean L. Schorno CPA

Executive VP & CFO

Mr. Raymond J. Furey J.D.

Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary

FAQs

What is Rigel Pharmaceuticals Inc share price today?

Rigel Pharmaceuticals Inc share price today is $36.97 as on . Rigel Pharmaceuticals Inc share today touched a day high of $38.64 and a low of $36.7.

What is the 52 week high and 52 week low for Rigel Pharmaceuticals Inc share?

Rigel Pharmaceuticals Inc share touched a 52 week high of $43.72 on and a 52 week low of $13.37 on . Rigel Pharmaceuticals Inc stock price today i.e. is trending at $36.97,which is 15.44% down from its 52 week high and 176.51% up from its 52 week low.

What is Rigel Pharmaceuticals Inc's market capitalisation today?

Rigel Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Rigel Pharmaceuticals Inc Stock (RIGL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rigel Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rigel Pharmaceuticals Inc Shares that will get you 0.0406 shares as per Rigel Pharmaceuticals Inc share price of $36.97 per share as on September 15, 2025 at 9:42 pm IST.

What is the minimum amount required to buy Rigel Pharmaceuticals Inc Stock (RIGL) from India?

Indian investors can start investing in Rigel Pharmaceuticals Inc (RIGL) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Rigel Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Rigel Pharmaceuticals Inc share’s latest price of $36.97 as on September 15, 2025 at 9:42 pm IST, you will get 0.2705 shares of Rigel Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Rigel Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Rigel Pharmaceuticals Inc stock has given 53.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?